Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TI

Clinical trial NCT01140321 · COMPLETED

Trial details

NCT number: NCT01140321
Sponsor: Ente Ospedaliero Ospedali Galliera
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Osteoporosis Thalassemia Major Thalassemia Intermedia

Start date: 2004-01-01
Primary completion: 2010-05-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.